Global Metronidazole Injection Market Research Report 2023

Publication ID:

PB504243141

Publication Date:

May 4, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Metronidazole Injection is a sterile, parenteral dosage form of metronidazole in water. Metronidazole is classified as a synthetic antibacterial and antiprotozoal agent and is administered by the intravenous route. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Metronidazole Injection and other antibacterial drugs, Metronidazole Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Metronidazole injection is used to treat certain skin, blood, bone, joint, gynecologic, and abdominal (stomach area) infections caused by bacteria. It is also used to treat endocarditis (infection of the heart lining and valves), meningitis (infection of the membranes that surround the brain and spinal cord), and certain respiratory infections, including pneumonia. Metronidazole injection is also to prevent infection when used before, during, and after colorectal surgery. Metronidazole injection is in a class of medications called antibacterials. It works by killing bacteria and protozoa that cause infection.
Highlights
The global Metronidazole Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Metronidazole Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Metronidazole Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Metronidazole Injection include Pfizer, B. Braun Medical Inc, Sanofi-Aventis Canada Inc, Baxter, JB Chemicals and Pharmaceuticals, Qatar Pharma, Unique Pharmaceuticals, Sagent Pharmaceuticals and AdvaCare Pharma, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Metronidazole Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metronidazole Injection.
The Metronidazole Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Metronidazole Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metronidazole Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma
Segment by Type
500mg/100mL
50mg/10mL
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metronidazole Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metronidazole Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Metronidazole Injection Market Overview
1.1 Product Overview and Scope of Metronidazole Injection
1.2 Metronidazole Injection Segment by Type
1.2.1 Global Metronidazole Injection Market Value Comparison by Type (2023-2029)
1.2.2 500mg/100mL
1.2.3 50mg/10mL
1.3 Metronidazole Injection Segment by Application
1.3.1 Global Metronidazole Injection Market Value by Application: (2023-2029)
1.3.2 Adult Use
1.3.3 Pediatric Use
1.3.4 Geriatric Use
1.4 Global Metronidazole Injection Market Size Estimates and Forecasts
1.4.1 Global Metronidazole Injection Revenue 2018-2029
1.4.2 Global Metronidazole Injection Sales 2018-2029
1.4.3 Global Metronidazole Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Metronidazole Injection Market Competition by Manufacturers
2.1 Global Metronidazole Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Metronidazole Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Metronidazole Injection Average Price by Manufacturers (2018-2023)
2.4 Global Metronidazole Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Metronidazole Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metronidazole Injection, Product Type & Application
2.7 Metronidazole Injection Market Competitive Situation and Trends
2.7.1 Metronidazole Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Metronidazole Injection Players Market Share by Revenue
2.7.3 Global Metronidazole Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Metronidazole Injection Retrospective Market Scenario by Region
3.1 Global Metronidazole Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Metronidazole Injection Global Metronidazole Injection Sales by Region: 2018-2029
3.2.1 Global Metronidazole Injection Sales by Region: 2018-2023
3.2.2 Global Metronidazole Injection Sales by Region: 2024-2029
3.3 Global Metronidazole Injection Global Metronidazole Injection Revenue by Region: 2018-2029
3.3.1 Global Metronidazole Injection Revenue by Region: 2018-2023
3.3.2 Global Metronidazole Injection Revenue by Region: 2024-2029
3.4 North America Metronidazole Injection Market Facts & Figures by Country
3.4.1 North America Metronidazole Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Metronidazole Injection Sales by Country (2018-2029)
3.4.3 North America Metronidazole Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Metronidazole Injection Market Facts & Figures by Country
3.5.1 Europe Metronidazole Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Metronidazole Injection Sales by Country (2018-2029)
3.5.3 Europe Metronidazole Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metronidazole Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Metronidazole Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Metronidazole Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Metronidazole Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Metronidazole Injection Market Facts & Figures by Country
3.7.1 Latin America Metronidazole Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Metronidazole Injection Sales by Country (2018-2029)
3.7.3 Latin America Metronidazole Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metronidazole Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Metronidazole Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Metronidazole Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Metronidazole Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Metronidazole Injection Sales by Type (2018-2029)
4.1.1 Global Metronidazole Injection Sales by Type (2018-2023)
4.1.2 Global Metronidazole Injection Sales by Type (2024-2029)
4.1.3 Global Metronidazole Injection Sales Market Share by Type (2018-2029)
4.2 Global Metronidazole Injection Revenue by Type (2018-2029)
4.2.1 Global Metronidazole Injection Revenue by Type (2018-2023)
4.2.2 Global Metronidazole Injection Revenue by Type (2024-2029)
4.2.3 Global Metronidazole Injection Revenue Market Share by Type (2018-2029)
4.3 Global Metronidazole Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Metronidazole Injection Sales by Application (2018-2029)
5.1.1 Global Metronidazole Injection Sales by Application (2018-2023)
5.1.2 Global Metronidazole Injection Sales by Application (2024-2029)
5.1.3 Global Metronidazole Injection Sales Market Share by Application (2018-2029)
5.2 Global Metronidazole Injection Revenue by Application (2018-2029)
5.2.1 Global Metronidazole Injection Revenue by Application (2018-2023)
5.2.2 Global Metronidazole Injection Revenue by Application (2024-2029)
5.2.3 Global Metronidazole Injection Revenue Market Share by Application (2018-2029)
5.3 Global Metronidazole Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Metronidazole Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Metronidazole Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 B. Braun Medical Inc
6.2.1 B. Braun Medical Inc Corporation Information
6.2.2 B. Braun Medical Inc Description and Business Overview
6.2.3 B. Braun Medical Inc Metronidazole Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 B. Braun Medical Inc Metronidazole Injection Product Portfolio
6.2.5 B. Braun Medical Inc Recent Developments/Updates
6.3 Sanofi-Aventis Canada Inc
6.3.1 Sanofi-Aventis Canada Inc Corporation Information
6.3.2 Sanofi-Aventis Canada Inc Description and Business Overview
6.3.3 Sanofi-Aventis Canada Inc Metronidazole Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi-Aventis Canada Inc Metronidazole Injection Product Portfolio
6.3.5 Sanofi-Aventis Canada Inc Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Corporation Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Metronidazole Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxter Metronidazole Injection Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 JB Chemicals and Pharmaceuticals
6.5.1 JB Chemicals and Pharmaceuticals Corporation Information
6.5.2 JB Chemicals and Pharmaceuticals Description and Business Overview
6.5.3 JB Chemicals and Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 JB Chemicals and Pharmaceuticals Metronidazole Injection Product Portfolio
6.5.5 JB Chemicals and Pharmaceuticals Recent Developments/Updates
6.6 Qatar Pharma
6.6.1 Qatar Pharma Corporation Information
6.6.2 Qatar Pharma Description and Business Overview
6.6.3 Qatar Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Qatar Pharma Metronidazole Injection Product Portfolio
6.6.5 Qatar Pharma Recent Developments/Updates
6.7 Unique Pharmaceuticals
6.6.1 Unique Pharmaceuticals Corporation Information
6.6.2 Unique Pharmaceuticals Description and Business Overview
6.6.3 Unique Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Unique Pharmaceuticals Metronidazole Injection Product Portfolio
6.7.5 Unique Pharmaceuticals Recent Developments/Updates
6.8 Sagent Pharmaceuticals
6.8.1 Sagent Pharmaceuticals Corporation Information
6.8.2 Sagent Pharmaceuticals Description and Business Overview
6.8.3 Sagent Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sagent Pharmaceuticals Metronidazole Injection Product Portfolio
6.8.5 Sagent Pharmaceuticals Recent Developments/Updates
6.9 AdvaCare Pharma
6.9.1 AdvaCare Pharma Corporation Information
6.9.2 AdvaCare Pharma Description and Business Overview
6.9.3 AdvaCare Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 AdvaCare Pharma Metronidazole Injection Product Portfolio
6.9.5 AdvaCare Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metronidazole Injection Industry Chain Analysis
7.2 Metronidazole Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metronidazole Injection Production Mode & Process
7.4 Metronidazole Injection Sales and Marketing
7.4.1 Metronidazole Injection Sales Channels
7.4.2 Metronidazole Injection Distributors
7.5 Metronidazole Injection Customers
8 Metronidazole Injection Market Dynamics
8.1 Metronidazole Injection Industry Trends
8.2 Metronidazole Injection Market Drivers
8.3 Metronidazole Injection Market Challenges
8.4 Metronidazole Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂